Alex Martin Martin
Director/Board Member at ESSA PHARMA INC.
Net worth: 121 399 $ as of 2024-03-30
Profile
John Alexander Martin is currently the Chief Executive Officer at Abcuro, Inc. and the Chief Executive Officer & Director at Palladio Biosciences, Inc. He is also the Chairman at Veralox Therapeutics, Inc. and an Independent Director at ESSA Pharma, Inc. Previously, he served as the Chief Executive Officer at Affectis Pharmaceuticals AG and Realm Therapeutics, Inc. He was also the Managing Director at The Sophocles Group LLC and the VP-Global Business Development & Licensing at Novartis Pharmaceuticals Corp.
He holds an undergraduate degree from Cornell University and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ESSA PHARMA INC
0.03% | 2024-03-24 | 14,299 ( 0.03% ) | 121 399 $ | 2024-03-30 |
Alex Martin Martin active positions
| Companies | Position | Start |
|---|---|---|
| ESSA PHARMA INC. | Director/Board Member | 2019-07-30 |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Chairman | 2020-09-16 |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Chief Executive Officer | 2019-08-07 |
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA. | Chief Executive Officer | - |
Former positions of Alex Martin Martin
| Companies | Position | End |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Director/Board Member | 2019-07-09 |
| Realm Therapeutics, Inc. | Chief Executive Officer | 2019-06-30 |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Corporate Officer/Principal | 2015-04-30 |
| UNIGENE LABORATORIES INC | Corporate Officer/Principal | 2011-05-31 |
The Sophocles Group LLC
 The Sophocles Group LLC Financial ConglomeratesFinance The Sophocles Group LLC provides investment services. The private company is based in Princeton. | Corporate Officer/Principal | 2010-12-31 |
Training of Alex Martin Martin
| Cornell University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| ESSA PHARMA INC. | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| Private companies | 14 |
|---|---|
Unigene Laboratories, Inc.
 Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
Medscape, Inc.
 Medscape, Inc. Data Processing ServicesTechnology Services Medscape, Inc. operates a web site that provides medical information and interactive medical programs. It provides a wide array of healthcare information to individual, small group, network healthcare providers, pharmaceutical industry and consumers. The company was founded in 1995 and is located in New York, NY. | Technology Services |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | Health Technology |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Affectis Pharmaceuticals AG
 Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
| Realm Therapeutics, Inc. | |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA. | Commercial Services |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Health Technology |
The Sophocles Group LLC
The Sophocles Group LLC Financial ConglomeratesFinance The Sophocles Group LLC provides investment services. The private company is based in Princeton. | Finance |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
| Smithkline Beecham Pharmaceuticals (Canada) |
- Stock Market
- Insiders
- Alex Martin Martin
